THE EFFECTS OF CARVEDILOL AND Q10 ON ISOPRENALINE-INDUCED CARDIOTOXICITY: ELECTROCARDIOGRAPHIC, BIOCHEMICAL AND HISTOPATHOLOGICAL EVALUATION IN RATS.

N. Elshourbagy
{"title":"THE EFFECTS OF CARVEDILOL AND Q10 ON ISOPRENALINE-INDUCED CARDIOTOXICITY: ELECTROCARDIOGRAPHIC, BIOCHEMICAL AND HISTOPATHOLOGICAL EVALUATION IN RATS.","authors":"N. Elshourbagy","doi":"10.21608/ajps.2018.6640","DOIUrl":null,"url":null,"abstract":"Objective: To assess the therapeutic effect of combining of Carvedilol and Q10 on electrocardiographic, biochemical and histopathological changes in isoprenaline induced myocardial infarction. Methods: Myocardial infarction was induced in rats by subcutaneous (s.c) injection of isoprenaline (85mg/kg) for two consecutive days at an interval of 24 h. Rats were treated orally (p.o) with Carvedilol at dose (5 mg/kg/day) and Q10 at dose (10 mg/kg/day) for a period of 14 days. At the end of experiment electrocardiographic, biochemical and histopathological changes were monitored from control and experimental groups. Results: ISP intoxicated rats showed a significant tachycardia , elevation ST and prolongation of QTc (i.e. ST, QTc & HR) due to conduction abnormalities, increased serum creatine kinase isoenzyme-MB (CK-MB) Treatment with Carv+Q10 significantly improved the ISP induced alteration in ECG, biochemical and histopathological changes. Conclusions: The present result shows that treatment with Carv+Q10 significantly attenuates myocardial infarction in ISPintoxicated rats.","PeriodicalId":7603,"journal":{"name":"Al-Azhar Journal of Pharmaceutical Sciences","volume":"48 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Al-Azhar Journal of Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/ajps.2018.6640","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Objective: To assess the therapeutic effect of combining of Carvedilol and Q10 on electrocardiographic, biochemical and histopathological changes in isoprenaline induced myocardial infarction. Methods: Myocardial infarction was induced in rats by subcutaneous (s.c) injection of isoprenaline (85mg/kg) for two consecutive days at an interval of 24 h. Rats were treated orally (p.o) with Carvedilol at dose (5 mg/kg/day) and Q10 at dose (10 mg/kg/day) for a period of 14 days. At the end of experiment electrocardiographic, biochemical and histopathological changes were monitored from control and experimental groups. Results: ISP intoxicated rats showed a significant tachycardia , elevation ST and prolongation of QTc (i.e. ST, QTc & HR) due to conduction abnormalities, increased serum creatine kinase isoenzyme-MB (CK-MB) Treatment with Carv+Q10 significantly improved the ISP induced alteration in ECG, biochemical and histopathological changes. Conclusions: The present result shows that treatment with Carv+Q10 significantly attenuates myocardial infarction in ISPintoxicated rats.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
卡维地洛和q10对异丙肾上腺碱诱导的大鼠心脏毒性的影响:心电图、生化和组织病理学评价。
目的:评价卡维地洛联合辅酶Q10对异丙肾上腺素所致心肌梗死的心电图、生化及病理组织学改变的影响。方法:连续2天皮下注射异丙肾上腺素(85mg/kg)诱导大鼠心肌梗死,间隔24 h。大鼠口服卡维地洛(5mg/kg /d)和辅酶Q10 (10mg /kg/d),连续14天。实验结束时,观察对照组和试验组大鼠心电图、生化及组织病理学变化。结果:ISP中毒大鼠由于传导异常出现明显的心动过速、ST升高和QTc(即ST、QTc和HR)延长,血清肌酸激酶同工酶- mb (CK-MB)升高。Carv+Q10治疗可显著改善ISP诱导的心电图、生化和组织病理学改变。结论:Carv+Q10可显著减轻ispintoxig大鼠心肌梗死。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
FORMULATION AND CHARACTERIZATIONS OF ROSUVASTATIN LOADED NANOSUSPENSION COMPARATIVE EVALUATION OF ANTICANCER AND ANTIBACTERIAL ACTIVITIES OF ENDOPHYTIC FUNGUS-DERIVED ZNO NANOPARTICLES AND CHEMICALLY SYNTHESIZED ZNO NANOPARTICLES PREPARATION AND EVALUATION OF SUSTAINED RELEASE MATRIX FORMULATIONS OF VORICONAZOLE PIM KINASES INHIBITORS AND PYRIMIDINE-BASED ANTICANCER AGENTS RECENT ADVANCES ON PYRIMIDINE DERIVATIVES AS ANTICANCER AGENTS.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1